-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $19

Benzinga·02/23/2026 15:04:24
Listen to the news
RBC Capital analyst Ben Hendrix maintains Select Medical Hldgs (NYSE:SEM) with a Outperform and lowers the price target from $20 to $19.